March 23 (Reuters) - Gilead Sciences Inc shares slid 2 percent on Monday after the company warned about potentially fatal risks for patients being treated with its top-selling hepatitis c drugs who also take the potent heart drug amiodarone.
March 18 (Reuters) - Charity Medecins Sans Frontieres has accused U.S. drugmaker Gilead Sciences Inc of restricting access to its breakthrough hepatitis C drug Sovaldi in developing countries as it tries to protect profit margin in wealthier nations.
countries and contributing to revenues of $1 billion a year in Cuban pharmaceutical exports. YM BioSciences was acquired by Giliad Sciences in 2013, and Singapore-based Innokeys acquired its stake in the joint venture with CIMAB. Iznaga-Escobar is now chief
Feb 4 (Reuters) - Healthcare shares plunged on Wednesday, lead by biotechnology stocks, after Gilead Sciences Inc said it gave health insurers steeper-than-expected discounts on its hepatitis C...
Gilead Sciences reported fourth-quarter results and ..... the next couple of years, we believe Gilead 's portfolio and pipeline are diverse ..... the firm's wide moat looks secure. Gilead 's $3.8 billion in hepatitis C revenue
Jan 26 (Reuters) - Pharmacy benefits manager EnvisionRx said on Monday it reached an agreement to provide its customers with Gilead Sciences Inc 's hepatitis C drugs on an exclusive basis, the latest...
the Year. Under his leadership, Gilead Sciences ' focus on infectious disease has ..... oncology. Martin, who is also Gilead ’s chairman, has shown exemplary ..... independence and qualifications. Gilead 's moat was formed by its leadership
Jan 8 (Reuters) - Health insurer Anthem Inc on Thursday said it reached a deal under which Gilead Sciences Inc 's hepatitis C drug Harvoni will be the primary treatment for patients infected with the...
names during the year, including Applied Materials AMAT "> AMAT , Iron Mountain IRM "> IRM , Apple, and Gilead Sciences GILD "> GILD . Even so, its year-to-date performance is only marginally better than the performance of the S&P 500
investorsentimentreadings.html Bullish stories: Carnival & Royal Caribbean Cruises [ CCL; RCL ; pg 21]; FMC [pg 23; see link below]; Gilead [ GILD ; pg 25]; Korean steel maker Posco [ PKX ; pg 25]; Nestle [NESN.sw/ NSRGY ; CEO spotlight on Paul Bulcke ; pg 56